Dimensional Fund Advisors
ACER

Dimensional Fund Advisors’s Acer Therapeutics Inc ACER Stock Holding History

Dimensional Fund Advisors’s Portfolio ACER Stock Details ACER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-14,665
Closed -$42K – 3544
2021
Q2 		$42K Sell
14,665
-6,628
-31% -$19.1K ﹤0.01% 3444
2021
Q1 		$66K Buy
+21,293
New +$72.4K ﹤0.01% 3379
2019
Q4 		– Sell
-11,330
Closed -$36K – 3411
2019
Q3 		$36K Sell
11,330
-299
-3% -$877 ﹤0.01% 3399
2019
Q2 		$45K Buy
+11,629
New +$222K ﹤0.01% 3430

Other funds holding ACER

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Dimensional Fund Advisors's ACER Position: Q3 2021 in Review

Dimensional Fund Advisors sold out of Acer Therapeutics Inc (ACER) in Q3 2021, closing a stake of 14,665 shares — an estimated $42K sold.

Dimensional Fund Advisors first reported a position in ACER in Q2 2019 and held it in 4 quarters. The position peaked at $66K in Q1 2021. 25 funds tracked by Wall St. Rank hold ACER as of Q3 2021.

  • Dimensional Fund Advisors reported no remaining Acer Therapeutics Inc position as of Q3 2021 after selling out during the quarter.
  • Dimensional Fund Advisors sold 14,665 Acer Therapeutics Inc shares in Q3 2021, an estimated $42K.
  • Dimensional Fund Advisors first reported a position in Acer Therapeutics Inc in Q2 2019 and held it in 4 quarters.
  • Dimensional Fund Advisors's Acer Therapeutics Inc position peaked at $66K in Q1 2021.
  • 25 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q3 2021.

Based on Dimensional Fund Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.